"10.1371_journal.pone.0023208","plos one","2011-10-20T00:00:00Z","Shaija Samuel; Puja Gaur; Fan Fan; Ling Xia; Michael J Gray; Nikolaos A Dallas; Debashish Bose; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Greg Plowman; Anil Bagri; Anil K Sood; Lee M Ellis","Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Center for RNA Interference and Non-Coding RNA, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America; Tumor Biology and Angiogenesis, Genentech, Inc., South San Francisco, California, United States of America","Conceived and designed the experiments: SS LE. Performed the experiments: SS PG FF LX MG ND DB. Analyzed the data: SS LE. Contributed reagents/materials/analysis tools: SS CR-A GL-B AS GP AB. Wrote the paper: SS LE.","LE is a consultant to Genentech, Inc., who provided the NRP-2 antibodies, and to Roche. GP and AB were paid employees of Genentech at the time of the study. A patent application has been filed relating to the anti-NRP antibodies from Genentech that were used in this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","10","Shaija Samuel","SS",13,TRUE,2,7,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
